Peptide deformylase, mitochondrial
Also known as: DEFM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBH1
- Gene
- Ensembl
- ENSG00000258429
- Chromosome
- 16
- Canonical length
- 243 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells. [provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
243 residues, UniProt reviewed canonical sequence.
>Q9HBH1|PDF
1 MARLWGALSL WPLWAAVPWG GAAAVGVRAC SSTAAPDGVE GPALRRSYWR HLRRLVLGPP
61 EPPFSHVCQV GDPVLRGVAA PVERAQLGGP ELQRLTQRLV QVMRRRRCVG LSAPQLGVPR
121 QVLALELPEA LCRECPPRQR ALRQMEPFPL RVFVNPSLRV LDSRLVTFPE GCESVAGFLA
181 CVPRFQAVQI SGLDPNGEQV VWQASGWAAR IIQHEMDHLQ GCLFIDKMDS RTFTNVYWMK
241 VNDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 6 nTPM
Expression across tissuesHPA
Tissue
- liver: 6 nTPM
- kidney: 4.8 nTPM
- skeletal muscle: 4.2 nTPM
- pancreas: 3.2 nTPM
- esophagus: 2.9 nTPM
- adrenal gland: 2.4 nTPM
Single-cell type
- conjunctival goblet cells: 1 nCPM
- megakaryocyte progenitors: 0.9 nCPM
- plasma cells: 0.7 nCPM
- megakaryocyte-erythroid progenitors: 0.6 nCPM
- alveolar cells type 1: 0.4 nCPM
- endometrial ciliated cells: 0.4 nCPM
Immune cell
- naive B-cell: 4.1 nTPM
- naive CD4 T-cell: 1.5 nTPM
- basophil: 1.3 nTPM
- plasmacytoid DC: 1.3 nTPM
- memory B-cell: 1.2 nTPM
- memory CD8 T-cell: 1.2 nTPM
Brain region
- hippocampal formation: 9.8 nTPM
- cerebellum: 9 nTPM
- cerebral cortex: 8.9 nTPM
- choroid plexus: 8.4 nTPM
- white matter: 8.2 nTPM
- medulla oblongata: 8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.9
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.19
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- peptidyl-methionine modification
- positive regulation of cell population proliferation
- post-translational protein modification
- translation
Molecular functions
- metal ion binding
- peptide deformylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptide deformylase
- Peptide deformylase superfamily
- Polypeptide deformylase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDF as an antibody target. Whether an autoantibody or antibody against PDF could matter depends on whether native PDF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...